Showing 1,861 - 1,880 results of 2,530 for search '"Vaccine"', query time: 0.14s Refine Results
  1. 1861
  2. 1862
  3. 1863
  4. 1864
  5. 1865
  6. 1866

    Defining indicators for disease burden, health outcomes, policies and barriers and facilitators to health services for migrant populations in the Middle East and North African regi... by Charles Agyemang, Ali Ardalan, Farah Seedat, Bouchra Assarag, Nuria Casamitjana, Kolitha Wickramage, Sally Hargreaves, Ana Requena-Mendez, Fouad M Fouad, Dominik Zenner, Anna Deal, Stella Evangelidou, Wafa Saidi, Chiaki Ito, Oumnia Bouaddi, Moudrick Abdellatifi, Alba Cuxart-Graell, Hassan Edries, Eman Elafef, Taha Maatoug, Anissa Ouahchi, Liv Mathilde Pampiri, Sara Arias, Adel Abdelkhalek, Ahmed Hamed Arisha, Ibrahim Ahmed Bani, Aasmaa Chaoui, Wafa Chemao-Elfihri, Kenza Hassouni, Mahmoud Hilali, Mohamed Khalis, Wejdene Mansour, Ali Mtiraoui, MENA Migrant Health Working Group, Asad Adam, Adnene Ben Haj Aissa, Salma Altyib, Hanen Ben Belgacem, Imane Belkhammar, Thomas Calvot, Luciana Ceretti, Nelly Chavassieux, Hassan Chrifi, Mohamed Douagi, Algdail Elnil, Gonzalo Fanjul, Ahmed Hamed, Abdedayem Khelifi, Lora Makhlouf, Maissa Mokni, Davide Olchini, Tarik Oufkir, Nasong Park, Giuseppe Raffa, Sandra Santafé, Alice Sironi, Fatma Temimi, Zeineb Turki

    Published 2024-07-01
    “…This protocol describes a suite of seven systematic reviews that aim to identify, appraise and synthesise the available evidence on the burden and health outcomes, policies and access (barriers and facilitators) related to these mobile populations in the region.Methods Seven systematic reviews will cover three questions to explore the: (1) burden and health outcomes, (2) policies and (3) healthcare barriers and facilitators for the following seven disease areas in migrants in the MENA region: tuberculosis, HIV and hepatitis B and C, malaria and neglected tropical diseases, diabetes, mental health, maternal and neonatal health, and vaccine-preventable diseases. We will search electronic databases for studies in any language (year 2000–2023), reference-check relevant publications and cross-check included studies with experts. …”
    Get full text
    Article
  7. 1867
  8. 1868
  9. 1869

    Decolonization Projects by Cornelius Ewuoso

    Published 2023-09-01
    “…Decolonization may target power, for example, changing who owns and distributes COVID-19 vaccines and who distributors exclude in the distribution of vaccines. …”
    Get full text
    Article
  10. 1870
  11. 1871
  12. 1872
  13. 1873
  14. 1874

    COVID-19: Understanding the New Variants of Concern by Ke-Yan Loo, Vengadesh Letchumanan

    Published 2022-12-01
    “…The first variant was Alpha, followed by the discovery of Beta, Gamma, Delta, and Omicron, being the latest variant of concern. Although vaccines were distributed worldwide to reduce the severity of the disease when infected with SARS-CoV-2, the emergence of new variants raised doubts about the efficacy of the available vaccines. …”
    Get full text
    Article
  15. 1875

    Analyzing factors of daily travel distances in Japan during the COVID-19 pandemic by Masaya Mori, Yuto Omae, Yohei Kakimoto, Makoto Sasaki, Jun Toyotani

    Published 2024-08-01
    “…However, after the spread of vaccination, the perception of infection risk may decrease. …”
    Get full text
    Article
  16. 1876

    Clinical course, management and outcomes of COVID-19 in HIV-infected renal transplant recipients: A case series by L Bertels, K Manning, A Redd, T du Toit, Z Barday, E Muller

    Published 2024-04-01
    “…All the COVID‐19‐positive patients had at least one comorbidity. Vaccination data were available for 24 patients, of whom 5 had refused SARS‐CoV‐2 vaccination. …”
    Get full text
    Article
  17. 1877
  18. 1878

    Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients by Sapoznik Sivan, Faranesh Suzan, Ortenberg Rona, Hamburger Tamar, Barak Vivian, Peretz Tamar, Schachter Jacob, Markel Gal, Lotem Michal

    Published 2012-01-01
    “…Here, we have used a different cohort of melanoma patients with regional or metastatic disease (N=49), treated with autologous vaccination. By monitoring sCEACAM1 in serum samples obtained prior to and after vaccination, we show that sCEACAM1 correlates with disease state, overall survival, and S100B. …”
    Get full text
    Article
  19. 1879

    A SEIR model for control of infectious diseases with constraints by M. H. A. Biswas, L. T. Paiva, MdR de Pinho

    Published 2014-02-01
    “…We study the solution of such problems when mixed state control constraints are used to impose upper bounds on the available vaccines at each instant of time. We also explore the possibility of imposing upper bounds on the number of susceptible individuals with and without limitations on the number of vaccines available. …”
    Get full text
    Article
  20. 1880